Over the last 7 days, the United States market has remained flat, although it has experienced a notable 28% increase over the past year and earnings are forecast to grow by 16% annually. In this context of overall growth, identifying stocks that may be trading below their fair value can offer opportunities for investors seeking to capitalize on potential undervaluation in the market.

Top 10 Undervalued Stocks Based On Cash Flows In The United States

Name	Current Price	Fair Value (Est)	Discount (Est)
Travere Therapeutics (TVTX)	$44.12	$87.95	49.8%
Sea (SE)	$86.20	$169.85	49.3%
Q2 Holdings (QTWO)	$51.23	$97.59	47.5%
Lumentum Holdings (LITE)	$949.93	$1855.75	48.8%
First Merchants (FRME)	$40.42	$77.51	47.9%
FB Financial (FBK)	$54.17	$103.19	47.5%
Cohu (COHU)	$45.59	$87.66	48%
Chemung Financial (CHMG)	$66.09	$127.22	48%
Capital One Financial (COF)	$191.91	$381.20	49.7%
AbbVie (ABBV)	$206.60	$397.73	48.1%

Here's a peek at a few of the choices from the screener.

Datadog (DDOG)

Overview: Datadog, Inc. operates an observability and security platform for cloud applications globally, with a market cap of approximately $50.02 billion.

Operations: The company generates revenue from its IT Infrastructure segment, amounting to approximately $3.43 billion.

Estimated Discount To Fair Value: 21.4%

Datadog is trading at US$140.53, below its estimated future cash flow value of US$178.84, suggesting undervaluation. Earnings are forecast to grow significantly at 30.4% annually over the next three years, outpacing the broader US market's growth rate of 16%. Recent product innovations like GPU Monitoring and Datadog Experiments highlight efforts to enhance operational efficiency and cost management in AI-driven environments, potentially supporting future cash flow improvements despite current low profit margins.

Lumentum Holdings (LITE)

Overview: Lumentum Holdings Inc. manufactures and sells optical and photonic products across the Americas, Asia-Pacific, Europe, the Middle East, and Africa with a market cap of approximately $6.78 billion.

Operations: Lumentum Holdings Inc.'s revenue is derived from the manufacture and sale of optical and photonic products across various regions including the Americas, Asia-Pacific, Europe, the Middle East, and Africa.

Estimated Discount To Fair Value: 48.8%

Lumentum Holdings, trading at US$949.93, is significantly undervalued compared to its estimated future cash flow value of US$1855.75. Despite recent volatility and insider selling, earnings are forecasted to grow substantially at 74.5% annually over the next three years, supported by strategic expansions like the new U.S. manufacturing facility and a multibillion-dollar collaboration with NVIDIA for AI infrastructure enhancements. However, debt coverage by operating cash flow remains a concern amidst these growth initiatives.

Eli Lilly (LLY)

Overview: Eli Lilly and Company is a global pharmaceutical firm that discovers, develops, manufactures, and markets human pharmaceutical products across the United States, Europe, China, Japan, and other international markets with a market cap of approximately $859.04 billion.

Operations: Eli Lilly's revenue segments include human pharmaceutical products marketed across the United States, Europe, China, Japan, and various international markets.

Estimated Discount To Fair Value: 31.8%

Eli Lilly, trading at US$963.33, is considerably undervalued relative to its estimated future cash flow value of US$1412.52. The company has raised its 2026 revenue guidance to between US$82 billion and US$85 billion, reflecting strong performance with Q1 sales reaching US$19.8 billion, up from US$12.7 billion a year ago. Despite high debt levels, earnings are projected to grow faster than the U.S. market at 16.64% annually, supported by strategic partnerships and product innovations like Foundayo for weight management.

Seize The Opportunity

• Click this link to deep-dive into the 148 companies within our Undervalued US Stocks Based On Cash Flows screener.
• Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks.
• Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide.

Seeking Other Investments?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.